Previous studies indicated that high immune/stromal/ESTIMATE scores were significantly correlated with poor prognosis and advanced tumor grade in LGG (33), suggesting the cancer promoting role of NUTF2 via facilitating stromal and immune cell infiltration in LGG. The gene discussed is NUTF2; the disease is neoplasm.